FDA Investigator Maria Joselopez Barragan, PhD
Maria Joselopez Barragan, PhD has conducted inspections on 14 sites in 8 countries as of 19 Nov 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
19 Nov 2018
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Korea (Republic of),
Spain,
United States of America,
Austria,
Germany,
Switzerland,
United Kingdom of Great Britain and Northern Ireland,
Netherlands
FDA Investigators that have inspected at least one site in common with Maria Joselopez Barragan, PhD:
Ademola O Daramola,
Aimee Cunningham, PhD,
Alicia M Mozzachio,
Amber D Brodas,
Amy C Jordan,
Amy N Chen,
Anastasia G Lolas,
Anastasia M Shields,
Anita Narula, PhD,
Anjali Shukla, PhD,
Antonina Aydanian,
Arie C Menachem,
Ashutosh Rao, PhD,
Barbara Janine Breithaupt,
Bazarragchaa Damdinsuren, PhD,
Bijoy Panicker,
Bo Chi, PhD,
Brandon C Heitmeier,
Brooke K Higgins,
Bruce H Mccullough,
Burnell M Henry,
Calvin B Koerner,
Candace Y Gomez Broughton,
Carla J Lundi,
Carolyn A Renshaw,
Caryn M Mcnab,
CDR Rochelle B Young, RPh, MSA,
Charisse K Green,
Charles Jewell,
Chen Sun, PhD,
Christina V Santos,
Concepcion Cruz, Jr,
Cynthia Jim, CSO,
Daryl A Dewoskin,
David G Eng,
David M Beltran,
Deborah Schmiel, PhD,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Dennis Cantellops Paite,
Dennis E Guilfoyle, PhD,
Diane L Raccasi,
Dianne S Alexander,
Dien N Nguyen,
Djamila Harouaka,
Dogbeda F Mackenzie,
Donald C Obenhuber, PhD,
Douglas A Campbell,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Dr. Willie Wilson, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Emest F Bizjak,
Erin L Mcfiren,
Frances Namuswe, PhD,
Freyja V Lynn,
Gerald B Seaborn, Jr,
Guerlain Ulysse,
Gwyn G Dickinson,
Haoheng Yan, PhD,
Helen B Ricalde,
Herbert M Corbello,
Holly Brevig,
Howard Anderson, PhD,
Hyung Yul Lee,
Ivis L Negron,
J Paul Kirwan, PhD,
Jacek Cieslak, PhD,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James C Maclaughlin,
James D Bridges,
James I Giefer,
Jay T Wong,
Jeffrey P Raimondi,
Jennifer L Bridgewater,
Jennifer M Gogley,
Jennifer Swisher, PhD,
Jens Fricke,
Jonathan W Chapman,
Jorge L Guadalupe,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose M Melendez,
Juhong Liu, PhD,
Julie D Bringger,
Kalavati Suvarna, PhD,
Karen A Briggs,
Karen L Kosar,
Katherine Szestypalow,
Kathleen R Jones, PhD,
Kevin A Gonzalez,
Kevin D Kallander,
Kevin P Foley,
Kristina L Conroy,
Lakshmi Narasimhan, PhD,
Lata C Mathew, PhD,
Laura Fontan, MS,
Laurel A Beer,
Lawrence J Stringer,
LCDR Chad N Thompson,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Li Lu, PhD,
Libia M Lugo,
Linda F Murphy,
Linda Thai,
Lori Peters,
Lucila B Nwatu,
Luis Mburgos Medero,
Lynda L Perry, PhD,
Maan S Abduldayem,
Madushini Dharmasena, PhD,
Margaret E Sarles,
Margaret M Annes,
Maria Cecilia Tami, PhD,
Maria Gutierrez Lugo, PhD,
Marion Michaelis,
Marjorie A Shapiro, PhD,
Mark R Mcclain,
Marlene G Swider,
Marsha W Major,
Martha T Olone,
Mary Davis Lopez,
Mary E Farbman, PhD,
Mary E Storch,
Maryam Tabatabaie,
Mate Tolnay,
Matthew A Spataro,
Matthew B Casale,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Meredith P Soehl, Investigator,
Michael Shanks, MS,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milan S Blake,
Milos Dokmanovic, PhD,
Mindy M Chou,
Monica Markovski, PhD,
Mra B Kamberem,
Mra Davism,
Mra Mcculloughj,
Mra Munizn,
Nadeem I Chaudhry,
Nancy T Waites,
Nealie C Newberger,
Nebil A Oumer,
Ogechi C Nna,
Omotunde O Osunsanmi,
Pankaj H Amin,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Patrick J Lynch,
Patrick L Wisor,
Patsy J Domingo,
Paul A Bonneau,
Paul L Bellamy,
Paul Mouris,
Paula A Trost,
Peggy M Speight,
Perry T Nichols,
Peter Adams, PhD,
Phillip Angart, PhD,
Prabhu P Raju,
Prajakta A Varadkar,
Qin Xu,
Rajiv R Srivastava,
Ram Sihag, PhD,
Raquel Gonzalez Rivera,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Richard W Thornton,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert J Martin,
Robert Jennings,
Robert Rodriguez,
Rose Ashley,
Ruth Moore, PhD,
Sang Bong Lee,
Sangeeta M Khurana, PhD,
Santos E Camara,
Sarah Arden,
Sarah B Tanksley,
Sarah Kennett, PhD,
Scott E Norris,
Scott R Nichols, PhD,
Sean Fitzsimmons,
Sean R Marcsisin,
Sena G Dissmeyer,
Simone E Pitts,
Sony Mathews,
Stacey S Degarmo,
Stephen D Eich,
Steven D Kehoe,
Steven Fong, MS, PhD,
Steven Kozlowski, MD,
Steven M Weinman,
Steven P Donald,
Susan F Laska, MS,
Susan M Jackson,
Susan P Bruederle,
Susan T Hadman,
Susanna E Ford,
Tamara L Ely,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Tina S Roecklein,
Truong Xuan Nguyen (Andy),
Tzanko Stantchev,
Vaishali J Patel,
Virginia Carroll, PhD,
Viviana Matta,
Wayne E Seifert,
Wendy G Tan, PhD,
William Hallett, PhD,
Xianghong Jing (Emily), PhD,
Xiaokuang Lai, PhD,
Xiaoping Guan,
Xu Michael Di, PhD,
Yasamin Ameri,
Yetao Jin, PhD,
Ying Xin Fan, PhD,
Yun Wu, PhD,
Yvins Dezan,
Zhao Wang, PhD,
Zhong Li, PhD,
Ziyang Su, PhD
Maria Joselopez Barragan, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2016 | FDA 483 | Sandoz GmbH - Form 483, 2016-03-11 |
| March, 2016 | FDA 483 | Sandoz GmbH - Form 483, 2016-03-11 |
| September, 2016 | EIR | Lonza Biologics Porrino SL - EIR, 2016-09-13 |
| July, 2017 | FDA 483 | Samsung Biologics Co., Ltd. - Form 483, 2017-07-25 |
| January, 2017 | FDA 483 | AstraZeneca Pharmaceuticals LP - Form 483, 2017-01-27 |
| March, 2017 | FDA 483 | Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2017-03-17 |
| December, 2017 | FDA 483 | Lonza AG - Form 483, 2017-12-15 |
| February, 2018 | FDA 483 | Patheon Biologics B.V. - Form 483, 2018-02-13 |
| November, 2018 | EIR | Boehringer Ingelheim RCV GmbH & Co KG - EIR, 2018-11-23 |
| March, 2017 | FDA 483 | Lonza Biologics, plc - Form 483, 2017-03-31 |
| September, 2016 | FDA 483 | Lonza Biologics Porrino SL - Form 483, 2016-09-13 |
| November, 2018 | FDA 483 | Boehringer Ingelheim RCV GmbH & Co KG - Form 483, 2018-11-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more